img

Global Disease Control and Prevention Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Disease Control and Prevention Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccines are biological entity used to activate acquired immunity to control or prevent particular disease or a group of disease. Immunization is carried out in infants as well as in adults. Vaccination against various bacterial and viral diseases is an integral part of infectious disease control world-wide.
Disease Control and Prevention Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Disease Control and Prevention Vaccine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Pediatric Vaccine and Adult Vaccine are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Disease Control and Prevention Vaccine industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Disease Control and Prevention Vaccine key manufacturers include GSK, Merck & Co., Inc, Pfizer, Sanofi, AstraZeneca PLC, Sinovac Biotech Ltd, Astellas Pharma Inc, Serum Institute of India Pvt. Ltd and Daiichi Sankyo, etc. GSK, Merck & Co., Inc, Pfizer are top 3 players and held % sales share in total in 2022.
Disease Control and Prevention Vaccine can be divided into Live-Attenuated, Inactivated and Recombinant Sub Unit and Toxoid,, etc. Live-Attenuated is the mainstream product in the market, accounting for % sales share globally in 2022.
Disease Control and Prevention Vaccine is widely used in various fields, such as Pediatric Vaccine and Adult Vaccine, etc. Pediatric Vaccine provides greatest supports to the Disease Control and Prevention Vaccine industry development. In 2022, global % sales of Disease Control and Prevention Vaccine went into Pediatric Vaccine filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Disease Control and Prevention Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GSK
Merck & Co., Inc
Pfizer
Sanofi
AstraZeneca PLC
Sinovac Biotech Ltd
Astellas Pharma Inc
Serum Institute of India Pvt. Ltd
Daiichi Sankyo
Segment by Type
Live-Attenuated
Inactivated
Recombinant Sub Unit and Toxoid

Segment by Application


Pediatric Vaccine
Adult Vaccine

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Disease Control and Prevention Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Disease Control and Prevention Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Disease Control and Prevention Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Disease Control and Prevention Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Disease Control and Prevention Vaccine introduction, etc. Disease Control and Prevention Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Disease Control and Prevention Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Disease Control and Prevention Vaccine Market Overview
1.1 Disease Control and Prevention Vaccine Product Overview
1.2 Disease Control and Prevention Vaccine Market Segment by Type
1.2.1 Live-Attenuated
1.2.2 Inactivated
1.2.3 Recombinant Sub Unit and Toxoid
1.3 Global Disease Control and Prevention Vaccine Market Size by Type
1.3.1 Global Disease Control and Prevention Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Disease Control and Prevention Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Disease Control and Prevention Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Disease Control and Prevention Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Disease Control and Prevention Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Disease Control and Prevention Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Disease Control and Prevention Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Disease Control and Prevention Vaccine Sales Breakdown by Type (2018-2024)
2 Global Disease Control and Prevention Vaccine Market Competition by Company
2.1 Global Top Players by Disease Control and Prevention Vaccine Sales (2018-2024)
2.2 Global Top Players by Disease Control and Prevention Vaccine Revenue (2018-2024)
2.3 Global Top Players by Disease Control and Prevention Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Disease Control and Prevention Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Disease Control and Prevention Vaccine Market Competitive Situation and Trends
2.5.1 Disease Control and Prevention Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Disease Control and Prevention Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
2.8 Key Manufacturers Disease Control and Prevention Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Disease Control and Prevention Vaccine Status and Outlook by Region
3.1 Global Disease Control and Prevention Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Disease Control and Prevention Vaccine Historic Market Size by Region
3.2.1 Global Disease Control and Prevention Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Disease Control and Prevention Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Disease Control and Prevention Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Disease Control and Prevention Vaccine Forecasted Market Size by Region
3.3.1 Global Disease Control and Prevention Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Disease Control and Prevention Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Disease Control and Prevention Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Disease Control and Prevention Vaccine by Application
4.1 Disease Control and Prevention Vaccine Market Segment by Application
4.1.1 Pediatric Vaccine
4.1.2 Adult Vaccine
4.2 Global Disease Control and Prevention Vaccine Market Size by Application
4.2.1 Global Disease Control and Prevention Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Disease Control and Prevention Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Disease Control and Prevention Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Disease Control and Prevention Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Disease Control and Prevention Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Disease Control and Prevention Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Disease Control and Prevention Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Disease Control and Prevention Vaccine Sales Breakdown by Application (2018-2024)
5 North America Disease Control and Prevention Vaccine by Country
5.1 North America Disease Control and Prevention Vaccine Historic Market Size by Country
5.1.1 North America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Disease Control and Prevention Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Disease Control and Prevention Vaccine Sales in Value by Country (2018-2024)
5.2 North America Disease Control and Prevention Vaccine Forecasted Market Size by Country
5.2.1 North America Disease Control and Prevention Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Disease Control and Prevention Vaccine Sales in Value by Country (2024-2034)
6 Europe Disease Control and Prevention Vaccine by Country
6.1 Europe Disease Control and Prevention Vaccine Historic Market Size by Country
6.1.1 Europe Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Disease Control and Prevention Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Disease Control and Prevention Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Disease Control and Prevention Vaccine Forecasted Market Size by Country
6.2.1 Europe Disease Control and Prevention Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Disease Control and Prevention Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Disease Control and Prevention Vaccine by Region
7.1 Asia-Pacific Disease Control and Prevention Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Disease Control and Prevention Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Disease Control and Prevention Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Disease Control and Prevention Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Disease Control and Prevention Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Disease Control and Prevention Vaccine Sales in Value by Region (2024-2034)
8 Latin America Disease Control and Prevention Vaccine by Country
8.1 Latin America Disease Control and Prevention Vaccine Historic Market Size by Country
8.1.1 Latin America Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Disease Control and Prevention Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Disease Control and Prevention Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Disease Control and Prevention Vaccine Forecasted Market Size by Country
8.2.1 Latin America Disease Control and Prevention Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Disease Control and Prevention Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Disease Control and Prevention Vaccine by Country
9.1 Middle East and Africa Disease Control and Prevention Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Disease Control and Prevention Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Disease Control and Prevention Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Disease Control and Prevention Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Disease Control and Prevention Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Disease Control and Prevention Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Disease Control and Prevention Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GSK Disease Control and Prevention Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Merck & Co., Inc
10.2.1 Merck & Co., Inc Company Information
10.2.2 Merck & Co., Inc Introduction and Business Overview
10.2.3 Merck & Co., Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck & Co., Inc Disease Control and Prevention Vaccine Products Offered
10.2.5 Merck & Co., Inc Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Disease Control and Prevention Vaccine Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi Disease Control and Prevention Vaccine Products Offered
10.4.5 Sanofi Recent Development
10.5 AstraZeneca PLC
10.5.1 AstraZeneca PLC Company Information
10.5.2 AstraZeneca PLC Introduction and Business Overview
10.5.3 AstraZeneca PLC Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca PLC Disease Control and Prevention Vaccine Products Offered
10.5.5 AstraZeneca PLC Recent Development
10.6 Sinovac Biotech Ltd
10.6.1 Sinovac Biotech Ltd Company Information
10.6.2 Sinovac Biotech Ltd Introduction and Business Overview
10.6.3 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sinovac Biotech Ltd Disease Control and Prevention Vaccine Products Offered
10.6.5 Sinovac Biotech Ltd Recent Development
10.7 Astellas Pharma Inc
10.7.1 Astellas Pharma Inc Company Information
10.7.2 Astellas Pharma Inc Introduction and Business Overview
10.7.3 Astellas Pharma Inc Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Astellas Pharma Inc Disease Control and Prevention Vaccine Products Offered
10.7.5 Astellas Pharma Inc Recent Development
10.8 Serum Institute of India Pvt. Ltd
10.8.1 Serum Institute of India Pvt. Ltd Company Information
10.8.2 Serum Institute of India Pvt. Ltd Introduction and Business Overview
10.8.3 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Products Offered
10.8.5 Serum Institute of India Pvt. Ltd Recent Development
10.9 Daiichi Sankyo
10.9.1 Daiichi Sankyo Company Information
10.9.2 Daiichi Sankyo Introduction and Business Overview
10.9.3 Daiichi Sankyo Disease Control and Prevention Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Daiichi Sankyo Disease Control and Prevention Vaccine Products Offered
10.9.5 Daiichi Sankyo Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Disease Control and Prevention Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Disease Control and Prevention Vaccine Industrial Chain Analysis
11.4 Disease Control and Prevention Vaccine Market Dynamics
11.4.1 Disease Control and Prevention Vaccine Industry Trends
11.4.2 Disease Control and Prevention Vaccine Market Drivers
11.4.3 Disease Control and Prevention Vaccine Market Challenges
11.4.4 Disease Control and Prevention Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Disease Control and Prevention Vaccine Distributors
12.3 Disease Control and Prevention Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live-Attenuated
Table 2. Major Company of Inactivated
Table 3. Major Company of Recombinant Sub Unit and Toxoid
Table 4. Global Disease Control and Prevention Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (K Units)
Table 6. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Disease Control and Prevention Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Disease Control and Prevention Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Disease Control and Prevention Vaccine Sales by Type (2024-2034) & (K Units)
Table 11. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Disease Control and Prevention Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Type (2024-2034)
Table 14. Global Disease Control and Prevention Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (K Units)
Table 16. North America Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Disease Control and Prevention Vaccine Sales (K Units) by Type (2018-2024)
Table 18. Europe Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Disease Control and Prevention Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Disease Control and Prevention Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Latin America Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Disease Control and Prevention Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Disease Control and Prevention Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Disease Control and Prevention Vaccine Sales by Company (2018-2024) & (K Units)
Table 26. Global Disease Control and Prevention Vaccine Sales Share by Company (2018-2024)
Table 27. Global Disease Control and Prevention Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Disease Control and Prevention Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Disease Control and Prevention Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Disease Control and Prevention Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Disease Control and Prevention Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Disease Control and Prevention Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Disease Control and Prevention Vaccine Market
Table 34. Key Manufacturers Disease Control and Prevention Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Disease Control and Prevention Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Disease Control and Prevention Vaccine Sales by Region (2018-2024) & (K Units)
Table 38. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Disease Control and Prevention Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Disease Control and Prevention Vaccine Sales by Region (2024-2034) & (K Units)
Table 43. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Disease Control and Prevention Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Region (2024-2034)
Table 46. Global Disease Control and Prevention Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Disease Control and Prevention Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (K Units)
Table 49. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Disease Control and Prevention Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Disease Control and Prevention Vaccine Sales by Application (2024-2034) & (K Units)
Table 54. Global Disease Control and Prevention Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Disease Control and Prevention Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Disease Control and Prevention Vaccine Sales Market Share in Value by Application (2024-2034)
Table 57. Global Disease Control and Prevention Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Disease Control and Prevention Vaccine Sales by Application (2018-2024) (K Units)
Table 59. North America Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Disease Control and Prevention Vaccine Sales by Application (2018-2024) (K Units)
Table 61. Europe Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Disease Control and Prevention Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Latin America Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Disease Control and Prevention Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (K Units)
Table 69. North America Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (K Units)
Table 73. North America Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (K Units)
Table 81. Europe Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Disease Control and Prevention Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Disease Control and Prevention Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Value by Country (2024-2034)
Table 108. GSK Company Information
Table 109. GSK Introduction and Business Overview
Table 110. GSK Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. GSK Disease Control and Prevention Vaccine Product
Table 112. GSK Recent Development
Table 113. Merck & Co., Inc Company Information
Table 114. Merck & Co., Inc Introduction and Business Overview
Table 115. Merck & Co., Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Merck & Co., Inc Disease Control and Prevention Vaccine Product
Table 117. Merck & Co., Inc Recent Development
Table 118. Pfizer Company Information
Table 119. Pfizer Introduction and Business Overview
Table 120. Pfizer Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Pfizer Disease Control and Prevention Vaccine Product
Table 122. Pfizer Recent Development
Table 123. Sanofi Company Information
Table 124. Sanofi Introduction and Business Overview
Table 125. Sanofi Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Sanofi Disease Control and Prevention Vaccine Product
Table 127. Sanofi Recent Development
Table 128. AstraZeneca PLC Company Information
Table 129. AstraZeneca PLC Introduction and Business Overview
Table 130. AstraZeneca PLC Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. AstraZeneca PLC Disease Control and Prevention Vaccine Product
Table 132. AstraZeneca PLC Recent Development
Table 133. Sinovac Biotech Ltd Company Information
Table 134. Sinovac Biotech Ltd Introduction and Business Overview
Table 135. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Sinovac Biotech Ltd Disease Control and Prevention Vaccine Product
Table 137. Sinovac Biotech Ltd Recent Development
Table 138. Astellas Pharma Inc Company Information
Table 139. Astellas Pharma Inc Introduction and Business Overview
Table 140. Astellas Pharma Inc Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Astellas Pharma Inc Disease Control and Prevention Vaccine Product
Table 142. Astellas Pharma Inc Recent Development
Table 143. Serum Institute of India Pvt. Ltd Company Information
Table 144. Serum Institute of India Pvt. Ltd Introduction and Business Overview
Table 145. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Serum Institute of India Pvt. Ltd Disease Control and Prevention Vaccine Product
Table 147. Serum Institute of India Pvt. Ltd Recent Development
Table 148. Daiichi Sankyo Company Information
Table 149. Daiichi Sankyo Introduction and Business Overview
Table 150. Daiichi Sankyo Disease Control and Prevention Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Daiichi Sankyo Disease Control and Prevention Vaccine Product
Table 152. Daiichi Sankyo Recent Development
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Disease Control and Prevention Vaccine Market Trends
Table 156. Disease Control and Prevention Vaccine Market Drivers
Table 157. Disease Control and Prevention Vaccine Market Challenges
Table 158. Disease Control and Prevention Vaccine Market Restraints
Table 159. Disease Control and Prevention Vaccine Distributors List
Table 160. Disease Control and Prevention Vaccine Downstream Customers
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Disease Control and Prevention Vaccine Product Picture
Figure 2. Global Disease Control and Prevention Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Disease Control and Prevention Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Disease Control and Prevention Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Live-Attenuated
Figure 6. Global Live-Attenuated Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Inactivated
Figure 8. Global Inactivated Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Recombinant Sub Unit and Toxoid
Figure 10. Global Recombinant Sub Unit and Toxoid Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Disease Control and Prevention Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Disease Control and Prevention Vaccine Sales Market Share by Type in 2022 & 2034
Figure 13. North America Disease Control and Prevention Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Disease Control and Prevention Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Disease Control and Prevention Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Disease Control and Prevention Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Disease Control and Prevention Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Disease Control and Prevention Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Disease Control and Prevention Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Disease Control and Prevention Vaccine Revenue in 2022
Figure 25. Disease Control and Prevention Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Pediatric Vaccine
Figure 27. Global Pediatric Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Adult Vaccine
Figure 29. Global Adult Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Global Disease Control and Prevention Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Disease Control and Prevention Vaccine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Disease Control and Prevention Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. North America Disease Control and Prevention Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Europe Disease Control and Prevention Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Disease Control and Prevention Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Disease Control and Prevention Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Disease Control and Prevention Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Disease Control and Prevention Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Disease Control and Prevention Vaccine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Disease Control and Prevention Vaccine Manufacturing Cost Structure
Figure 43. Disease Control and Prevention Vaccine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries